The Valley Desk

NCT03965494 · Interventional trial

AXL Inhibitor BGB324 in Treating Participants With Recurrent Glioblastoma Undergoing Surgery

Overall registry status Terminated

Early Phase 1

Conditions Brain and Central Nervous System Tumors

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov